Tom Bird
Principal
tom.bird@torreyapartners.com
(201) 893-1296
Tom is an accomplished life sciences executive and has completed several M&A transactions since joining Torreya in December 2007. He is strong in the areas of acquisitions, divestitures, licensing, partnerships and due diligence. Tom is also an accomplished strategic planner with a focus on planning process, development and implementation. His expertise lies in the world of specialty pharmaceuticals, life science tools, generic products and pharmaceutical manufacturing. Tom is also active in providing strategic consulting services to life science clients. He previously was Vice President, Corporate Development at Cambrex where he was involved in a number of divestitures and acquisitions. Tom was also a President of the Biosciences Group of Cambrex where he built BioWhittaker through acquisitions into a powerhouse in the supply business in cell biology, stem cells, electrophoresis gels and reagents. Previously, Tom was President of Nepera Chemical, President of Cuno, and President of the Consumer Products business of Sherwin-Williams. Tom received a B.A. from Muhlenberg College and conducted graduate studies at the University of New Hampshire.
Selected Transaction Experience:
• Columbia Labs, Sale of Progesterone Related Assets to Watson, $107.5 million (pending)
• Introgen Therapeutics, Corporate Restructuring (2008)
• AGI Dermatics, Sale to Estée Lauder (2008)
• ProEthic Pharmaceuticals, Sale to Kowa (2008)
• Midlothian Laboratories, Sale to Hi-Tech Pharmacal (2007)
• Cambrex, Sale of Manufacturing Facilities in Ireland and Belgium (2006)
• Cambrex, Sale of Bio-Subsidiaries to Lonza, $460 million (2006)
• Cambrex, Acquisition of Cutanogen (2006)
• Cambrex, Acquisition of Genolife (2004)
• Cambrex, Sale of Rutherford Chemicals (2003)
• Cambrex, Acquisition of Lumitech (2001)
• Cambrex, Alliance with SciQuest.com (2000)
• Cambrex, Equity Investment and Alliance with Osiris Therapeutics (1999)
• Cambrex, Acquisition of Poetic Technologies (1999)
• Cambrex, Acquisition of BioProducts Business from FMC (1999)
Copyright © 2010 Torreya Partners LLC. All rights reserved.
Securities offered through Financial West Group, member FINRA/SIPC. Torreya Partners LLC and Financial West Group are unaffiliated entities.